Skip to content

Author

Zi-Bo Feng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Dual Pathway Inhibition versus Dual Antiplatelet Therapy in Patients with Acute or nonacute Limb Ischemia: A Propensity Score-Matched Analysis from the RESOLVE Study.

OBJECTIVE Real-world evidence comparing dual-pathway inhibition (DPI) with dual antiplatelet therapy (DAPT) after endovascular revascularization for acute or nonacute limb ischemia is limited. This study aims to compare the 24-month effectiveness and safety outcomes of DPI versus DAPT in this setting. METHODS This pr...

Yu-Li Wang, Yang Liu, Chun-Shui He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.